Position in AMGN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$899,328
+$63,706 QoQ
Shares Held
2,556
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GM Advisory Group, LLC holds $19,630,085 across 10 Drug Manufacturers - General names. AMGN ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,002 | $9,199,539 | |
| 2 | JNJ |
Johnson & Johnson
|
14,495 | $3,543,157 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,762 | $2,136,590 | |
| 4 | ABBV |
AbbVie Inc.
|
7,400 | $1,609,426 | |
| 5 | PFE |
Pfizer Inc
|
32,594 | $915,239 | |
| 6 | AMGN |
Amgen Inc
This page
|
2,556 | $899,328 | |
| 7 | AZN |
Astrazeneca PLC
|
2,421 | $477,469 | |
| 8 | NVS |
Novartis AG
|
2,102 | $321,080 |
All Filings in AMGN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $899,328 | 2,556 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $835,622 | 2,553 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $666,838 | 2,363 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $741,860 | 2,657 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $384,764 | 1,235 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $252,299 | 968 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $308,354 | 957 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $299,014 | 957 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $277,780 | 977 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $275,635 | 957 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $257,203 | 957 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $213,583 | 962 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $260,606 | 1,078 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $211,950 | 807 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||